Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene Pietzak

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Urologic Oncology|July 10, 2022
Immune mechanisms and molecular therapeutic strategies to enhance immunotherapy in non-muscle invasive bladder cancer: Invited review for special issue "Seminar: Treatment Advances and Molecular Biology Insights in Urothelial Carcinoma"Carissa Chu, Eugene Pietzak
Current Urology Reports|January 6, 2025
Management of Lower Urinary Tract Symptoms during the Treatment for Non-Muscle Invasive Bladder CancerBenjamin Seiden, Divya Ajay, Felix Cheung, et al.
The Journal of Urology|March 27, 2017
Clinical Outcomes in Patients with Panurothelial Carcinoma Treated with Radical Nephroureterectomy Following Cystectomy for Metachronous RecurrenceQiang Li, Melissa Assel, Nicole Benfante, et al.
The Journal of Urology|November 21, 2025
Combination Strategies to Enhance Bacillus Calmette-Guérin Efficacy for Non-Muscle Invasive Bladder CancerGal Wald, Jacob Lang, Hassan Alkazemi, et al.
Briefings in Bioinformatics|August 14, 2020
An approach for normalization and quality control for NanoString RNA expression dataArjun Bhattacharya, Alina M Hamilton, Helena Furberg, et al.
European Urology Oncology|May 17, 2022
Contemporary Staging for Muscle-Invasive Bladder Cancer: Accuracy and LimitationsPatrick J Hensley, Valeria Panebianco, Eugene Pietzak, et al.
The Journal of Urology|August 8, 2025
Evaluating Benefits of Peristomal Mesh Placement at the Time of Radical Cystectomy and Ileal Conduit Formation: A Phase 3, Randomized Controlled TrialTimothy F Donahue, Melissa Assel, Eugene K Cha, et al.
The Journal of Urology|August 8, 2024
Randomized Trial of Transverse vs Vertical Extraction Site Incision After Robotic Radical ProstatectomyChristopher D Gaffney, Emily A Vertosick, Vincent Laudone, et al.
European Urology Focus|July 8, 2023
Background and Update for ECOG-ACRIN EA8212: A Randomized Phase 3 Trial of Intravesical Bacillus Calmette-Guérin (BCG) Versus Intravesical Docetaxel and Gemcitabine Treatment in BCG-naïve High-grade Non-muscle-invasive Bladder Cancer (BRIDGE)Max Kates, Xiangying Chu, Noah Hahn, et al.
The Journal of Urology|December 28, 2020
Examining the Accuracy of Self-Reported Smoking-Related Exposure among Recently Diagnosed Nonmuscle Invasive Bladder Cancer PatientsStacey Petruzella, Bernard H Bochner, Jessica Kenney, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Urologic Oncology|July 10, 2022
Immune mechanisms and molecular therapeutic strategies to enhance immunotherapy in non-muscle invasive bladder cancer: Invited review for special issue "Seminar: Treatment Advances and Molecular Biology Insights in Urothelial Carcinoma"Carissa Chu, Eugene Pietzak
Current Urology Reports|January 6, 2025
Management of Lower Urinary Tract Symptoms during the Treatment for Non-Muscle Invasive Bladder CancerBenjamin Seiden, Divya Ajay, Felix Cheung, et al.
The Journal of Urology|March 27, 2017
Clinical Outcomes in Patients with Panurothelial Carcinoma Treated with Radical Nephroureterectomy Following Cystectomy for Metachronous RecurrenceQiang Li, Melissa Assel, Nicole Benfante, et al.
The Journal of Urology|November 21, 2025
Combination Strategies to Enhance Bacillus Calmette-Guérin Efficacy for Non-Muscle Invasive Bladder CancerGal Wald, Jacob Lang, Hassan Alkazemi, et al.
Briefings in Bioinformatics|August 14, 2020
An approach for normalization and quality control for NanoString RNA expression dataArjun Bhattacharya, Alina M Hamilton, Helena Furberg, et al.
European Urology Oncology|May 17, 2022
Contemporary Staging for Muscle-Invasive Bladder Cancer: Accuracy and LimitationsPatrick J Hensley, Valeria Panebianco, Eugene Pietzak, et al.
The Journal of Urology|August 8, 2025
Evaluating Benefits of Peristomal Mesh Placement at the Time of Radical Cystectomy and Ileal Conduit Formation: A Phase 3, Randomized Controlled TrialTimothy F Donahue, Melissa Assel, Eugene K Cha, et al.
The Journal of Urology|August 8, 2024
Randomized Trial of Transverse vs Vertical Extraction Site Incision After Robotic Radical ProstatectomyChristopher D Gaffney, Emily A Vertosick, Vincent Laudone, et al.
European Urology Focus|July 8, 2023
Background and Update for ECOG-ACRIN EA8212: A Randomized Phase 3 Trial of Intravesical Bacillus Calmette-Guérin (BCG) Versus Intravesical Docetaxel and Gemcitabine Treatment in BCG-naïve High-grade Non-muscle-invasive Bladder Cancer (BRIDGE)Max Kates, Xiangying Chu, Noah Hahn, et al.
The Journal of Urology|December 28, 2020
Examining the Accuracy of Self-Reported Smoking-Related Exposure among Recently Diagnosed Nonmuscle Invasive Bladder Cancer PatientsStacey Petruzella, Bernard H Bochner, Jessica Kenney, et al.
Pageof 3